Suppr超能文献

验证加拿大囊性纤维化登记处的数据完整性和准确性。

Validating the Data Completeness and Accuracy of the Canadian Cystic Fibrosis Registry.

作者信息

Somayaji Ranjani, Cheng Stephanie Y, Abdulrahem Noma, Stanojevic Sanja, Eckford Paul, Quon Bradley S, Cromwell Elizabeth, Faro Albert, Goss Christopher H, Stephenson Anne L

机构信息

Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Cystic Fibrosis Canada, Toronto, Canada.

出版信息

Can Respir J. 2025 Jul 1;2025:8893074. doi: 10.1155/carj/8893074. eCollection 2025.

Abstract

The Canadian Cystic Fibrosis Registry (CCFR) was developed in the 1970s and has longitudinal demographic and clinical data on persons living with cystic fibrosis (CF) attending accredited clinics in Canada. We aimed to validate the data collection and identify potential limitations of the CCFR. Of 40 accredited CF clinics in Canada invited and based on an a priori sample size calculation, eight clinics were included. 15% of each CF clinic's population in 2019 were randomly selected. Data variables were selected based on their importance to care, epidemiologic trends, and data related to demography, clinic visits, and hospitalizations. The accuracy of the registry data was compared to the medical records as the gold standard. Each data element was categorized as correct, incorrect, or not able to be validated. The accuracy rate was calculated as the percent correct out of all records validated. A total of 4382 individuals had data entered into the CCFR in 2019. The validation cohort consisted of 208 individuals from 8 clinics, which were representative across location, size of clinic (small/medium/large), and type of clinic (adult, pediatric, and combined). The 208 individuals were 52% male and 95% White, and with a median age of 26.3 years (IQR: 15.2-36.6). Approximately 95% of CCFR data on clinical measurements, infections, treatments, and hospitalizations validated were accurate as compared to the medical record. For demography, sex and date of birth had 100% accuracy. Our validation of the CCFR demonstrated high accuracy for clinical and demographic variables used in clinical research.

摘要

加拿大囊性纤维化登记处(CCFR)始建于20世纪70年代,拥有在加拿大认可诊所就诊的囊性纤维化(CF)患者的纵向人口统计学和临床数据。我们旨在验证数据收集情况并识别CCFR的潜在局限性。在加拿大受邀的40家认可CF诊所中,根据预先计算的样本量,纳入了8家诊所。随机选取了2019年每家CF诊所15%的患者。根据数据变量对医疗护理的重要性、流行病学趋势以及与人口统计学、门诊就诊和住院相关的数据来选择数据变量。将登记处数据的准确性与作为金标准的病历进行比较。每个数据元素被分类为正确、不正确或无法验证。准确率计算为所有验证记录中正确记录的百分比。2019年共有4382人的数据录入了CCFR。验证队列由来自8家诊所的208名个体组成,这些个体在地理位置、诊所规模(小/中/大)和诊所类型(成人、儿科和综合)方面具有代表性。这208名个体中男性占52%,白人占95%,中位年龄为26.3岁(四分位间距:15.2 - 36.6)。与病历相比,CCFR中关于临床测量、感染、治疗和住院的验证数据约95%是准确的。在人口统计学方面,性别和出生日期的准确率为100%。我们对CCFR的验证表明,临床研究中使用的临床和人口统计学变量具有很高的准确性。

相似文献

4
Short-acting inhaled bronchodilators for cystic fibrosis.短效吸入性支气管扩张剂在囊性纤维化中的应用。
Cochrane Database Syst Rev. 2022 Jun 24;6(6):CD013666. doi: 10.1002/14651858.CD013666.pub2.
5
Exercise versus airway clearance techniques for people with cystic fibrosis.运动与气道廓清技术治疗囊性纤维化。
Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2.
7
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗。
Cochrane Database Syst Rev. 2024 May 3;5(5):CD009530. doi: 10.1002/14651858.CD009530.pub5.

本文引用的文献

2
Socioeconomic burden of cystic fibrosis in Canada.加拿大囊性纤维化的社会经济负担。
BMJ Open Respir Res. 2024 Aug 9;11(1):e002309. doi: 10.1136/bmjresp-2024-002309.
5
Contemporary cystic fibrosis incidence rates in Canada and the United States.加拿大和美国当代囊性纤维化发病率。
J Cyst Fibros. 2023 May;22(3):443-449. doi: 10.1016/j.jcf.2022.10.008. Epub 2022 Nov 10.
8
COVID-19 outcomes in people with cystic fibrosis.囊性纤维化患者的 COVID-19 结局。
Curr Opin Pulm Med. 2021 Nov 1;27(6):538-543. doi: 10.1097/MCP.0000000000000823.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验